|
 |
Prednisolone sodium phosphateThis page contains recent news articles, when available, and an overview of Prednisolone sodium phosphate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Prednisolone sodium phosphate (when available) Prednisolone is a synthetic glucocorticoid used as antiinflammatory or immunosuppressive agent. Prednisolone is indicated in the treatment of various conditions, including congenital adrenal hyperplasia, psoriatic arthritis, systemic lupus erythematosus, bullous dermatitis herpetiformis, seasonal or perennial allergic rhinitis, allergic corneal marginal ulcers, symptomatic sarcoidosis, idiopathic thrombocytopenic purpura in adults, leukemias and lymphomas in adults, and ulcerative colitis. Glucocorticoids are adrenocortical steroids and cause profound and varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli. For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders. Mechanism Of Action: Glucocorticoids such as Prednisolone can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Prednisolone reduces inflammatory reaction by limiting the capillary dilatation and permeability of the vascular structures. These compounds restrict the accumulation of polymorphonuclear leukocytes and macrophages and reduce the release of vasoactive kinins. Recent research suggests that corticosteroids may inhibit the release of arachidonic acid from phospholipids, thereby reducing the formation of prostaglandins. Prednisolone is a glucocorticoid receptor agonist. On binding, the corticoreceptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing an increase or decrease in expression of specific target genes, including suppression of IL2 (interleukin 2) expression. News Articles on Prednisolone … Regulations - 21 CFR § 522.1883 Prednisolone sodium phosphate. - Jul 11, 2006 21 CFR § 522.1883 Prednisolone sodium phosphate. (a) Specifications. Each milliliter of solution contains 20 milligrams (mg) prednisolone sodium phosphate ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw … - 77 Ill. Adm. Code 790.7380 PREDNISOLONE SODIUM PHOSPHATE ( … - Aug 10, 2005 77 Ill. Adm. Code 790.7380 PREDNISOLONE SODIUM PHOSPHATE (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw Prednisolone Sodium Phosphate Oral : User Ratings covering uses, … - Oct 15, 2007 So far, the drug seems to be working for me. I am feeling better and no longer have issues w/shortness of breath or wheezing. I had recurrent bronchitis (4 ... WebMD BioMarin Pharmaceutical Inc acquires API-Orapred NA Brand Rights from... - Mar 15, 2006 The license agreement grants BioMarin the exclusive worldwide rights to ORAPRED (prednisolone sodium phosphate), including proprietary… ... Pay-Per-View - deals - Alacra Store Press Release: American Pharmaceutical Partners Receives Approval for... - Apr 25, 2005 Hi-Tech's Prednisolone Sodium Phosphate Oral Solution is the generic equivalent of Celltech's Pediapred(R) Sodium Phosphate Oral Solution indicated for the ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: BioMarin Announces First Quarter 2007 Financial... - Apr 30, 2007 Orapred ODT(TM) (prednisolone sodium phosphate ... marketing approval of the drug in June. Orapred ODT is expected to be prescribed primarily ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin and Alliant Pharmaceuticals Announce North American … - Mar 15, 2006 Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: BioMarin and Alliant Pharmaceuticals Announce North … - Mar 15, 2006 Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin Files New Drug Application for Orapred ODT - Aug 1, 2005 ...for Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), ... and Orapred(R) (prednisolone sodium phosphate oral solution) for ... RedOrbit BioMarin Announces US FDA Acceptance of Orapred ODT Filing - Oct 19, 2005 ...for Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), ... and Orapred(R) (prednisolone sodium phosphate oral solution) for ... RedOrbit CET Services Inc acquires BioMedical Tech Solutions Inc - Deal … - Aug 21, 2008 Orapred (prednisolone sodium phosphate oral solution) is marketed by Alliant Pharmaceuticals… BIOMARIN PHARMACEUTICAL INC-DETAILED PRODUCT PIPELINE ... Pay-Per-View - deals - Alacra Store BioMarin Announces Third Quarter 2005 Financial Results. - Nov 1, 2005 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, of $0.2 million for the third ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin Announces Fourth Quarter and Year-End 2005 Financial … - Feb 23, 2006 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, were $0.4 million for the ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Orapred ODT Tastes Good. - PR Newswire | HighBeam … - Mar 29, 2007 S. Food and Drug Administration for Orapred ODT(TM) (prednisolone sodium phosphate ... including asthma, arthritis and cancer. ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin And Alliant Announce FDA Approval Of Orapred ODT - Jun 2, 2006 Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... Medical News Today - Medical News Today (press release) Press Release: BioMarin Announces US FDA Acceptance of Orapred … - Oct 19, 2005 ...for Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), ... and Orapred(R) (prednisolone sodium phosphate oral solution) for ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin Announces Third Quarter 2007 Financial Results. - Nov 1, 2007 ...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... Free with registration - PR Newswire - AccessMyLibrary.com Company Profile Report - Oct 4, 2008 Orapred ODT (Prednisolone Sodium Phosphate Orally Disintegrating Tablet); Orapred (Prednisolone Sodium Phosphate Oral Solution) ... $50.00 - Revere Reports - Revere Press Release: BioMarin Files New Drug Application for Orapred ODT. -... - Aug 1, 2005 ...for Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets), ... and Orapred(R) (prednisolone sodium phosphate oral solution) for ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin Announces First Quarter 2007 Financial Results. - Apr 30, 2007 ...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... Free with registration - PR Newswire - AccessMyLibrary.com Company Profile Report - Oct 4, 2008 Orapred (Prednisolone Sodium Phosphate Oral Solution); Orapred ODT (Prednisolone Sodium Phosphate Orally Disintegrating Tablet) ... $50.00 - Revere - Alacra Store Press Release: BioMarin and Alliant Announce FDA Approval of Orapred ... - Jun 1, 2006 Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... Pay-Per-View - PR Newswire - HighBeam Research Orapred ODT Tastes Good - Mar 30, 2007 Orapred ODT(TM) (Prednisolone sodium phosphate orally disintegrating tablets) is a prescription drug product indicated for the control of severe or ... RedOrbit Pennsylvania Code of Regulations - 28 Pa. Code § 25.58B. Generically ... - Jul 16, 2005 Steris Labs Steris Labs PREDNISOLONE SODIUM PHOSPHATE Ophthalmic Solution Predfair Pharmafair Pharmafair Prednisolone Sodium Phosphate United Research Labs ... Pay-Per-View - Pennsylvania Code of Regulations - Loislaw BioMarin Announces Second Quarter 2007 Financial Results. - Aug 7, 2007 ...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Orapred ODT Arrives in US Market. - PR Newswire | … - Aug 28, 2006 Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets) is marketed in the United States by Alliant Pharmaceuticals, pursuant to a ... Pay-Per-View - PR Newswire - HighBeam Research Asthma; BioMarin, Alliant report US Food and Drug Administration … - Jun 27, 2006 Orapred is a leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones BioMarin Announces Second Quarter 2005 Financial Results. - Aug 1, 2005 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including its branded and authorized generic products, decreased to $1.3 million for ... $4.95 - PR Newswire - ECNext BioMarin Announces Fourth Quarter and Full Year 2006 Financial... - Feb 20, 2007 ...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... $4.95 - PR Newswire - ECNext Merger and Acquisition Scenario - Sep 23, 2006 Target Products:. Orapred (Prednisolone Sodium Phosphate Oral Solution); Orapred ODT (Prednisolone Sodium Phosphate Orally Disintegrating Tablet) $250.00 - Revere Reports - Revere Drug Development; US FDA accepts Orapred ODT NDA filing - Nov 20, 2005 Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), a new formulation of Orapred (prednisolone sodium phosphate oral solution). ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Press Release: BioMarin Announces US Launch of Orapred ODT … - Aug 28, 2006 The Orapred product line, which includes Orapred ODT and Orapred(R) (prednisolone sodium phosphate oral solution) is marketed by Alliant Pharmaceuticals, ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin announces US FDA acceptance of Orapred ODT filing. - Oct 19, 2005 Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), a new formulation of Orapred (prednisolone sodium phosphate oral solution). ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com BioMarin Announces US Launch of Orapred ODT Through Alliant … - Aug 28, 2006 The Orapred product line, which includes Orapred ODT and Orapred(R) (prednisolone sodium phosphate oral solution) is marketed by Alliant Pharmaceuticals, ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin Announces Second Quarter 2006 Financial Results. - Aug 2, 2006 ...following FDA approval of Orapred ODT(TM) (prednisolone sodium phosphate ... including Orapred(R) (prednisolone sodium phosphate oral solution) and ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin Announces Year-End 2004 Product Revenues and 2005 … - Jan 26, 2005 The company's product portfolio is comprised of two approved products, Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma and ... $4.95 - PR Newswire - ECNext BioMarin Announces First Quarter 2006 Financial Results. - May 3, 2006 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, were $2.0 million for the ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin Announces Reduction of Orapred Sales Force. - Jul 5, 2005 ...it has eliminated 58 positions, of which 52 were held by personnel responsible for the sale of Orapred(R) (prednisolone sodium phosphate oral solution). ... $4.95 - PR Newswire - ECNext NutraCea to Present at Roth Capital Growth Conference and ViroPharma ... - Aug 29, 2006 The Orapred product line, which includes Orapred ODT and Orapred (prednisolone sodium phosphate oral solution) is marketed by Alliant Pharmaceuticals, Inc., ... Free with registration - M2 Presswire - AccessMyLibrary.com Releases Coverage for BioMarin Pharmaceutical Inc. - May 4, 2006 Net sales of Orapred (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, were $2.0 million for the first ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: Methylin Oral Solution is Child Preferred. - PR... - Oct 30, 2006 PR Newswire; August 28, 2006 ; 700+ words ... ... product line, which includes Orapred ODT and Orapred(R) (prednisolone sodium phosphate oral solution) is ... Pay-Per-View - PR Newswire - HighBeam Research Article: CAT SCAN: an update on Ohio's Commercial Activities Tax.( … - Jul 1, 2006 PR Newswire; June 1, 2006 ; 700+ words ... ... has granted marketing approval for Orapred ODT(TM) (prednisolone sodium phosphate orally . ... Pay-Per-View - Catalyst - HighBeam Research Article: NORTH SIDE RANCH PROVES JUST RIGHT WOMAN TRADED … - Jan 22, 2006 PR Newswire; June 1, 2006 ; 700+ words ... ... has granted marketing approval for Orapred ODT(TM) (prednisolone sodium phosphate orally . ... Pay-Per-View - Wisconsin State Journal - HighBeam Research Leave the pumping up for the gym; I want my meat unenhanced.(Food) | ... - Oct 8, 2008 Drug Administration approved the Abbreviated New Drug Application to manufacture and market the company's Prednisolone Sodium Phosphate Oral Solution. ... Pay-Per-View - Daily Herald - HighBeam Research BioMarin Announces Third Quarter 2006 Financial Results. - Nov 1, 2006 ...including Orapred(R) (prednisolone sodium phosphate oral solution) and Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... $4.95 - PR Newswire - ECNext Finance; BioMarin reports net loss of $0.02 per share - Aug 29, 2006 ...following FDA approval of Orapred ODT (prednisolone sodium phosphate orally ... including Orapred (prednisolone sodium phosphate oral solution) and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: BioMarin Announces Second Quarter 2006 Financial … - Aug 2, 2006 Administration has accepted for filing BioMarin Pharmaceutical's New Drug Application for Orapred ODT (prednisolone sodium phosphate orally . ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: BioMarin Announces First Quarter 2006 Financial... - May 3, 2006 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including the branded and authorized generic products, were $2.0 million for the ... Pay-Per-View - PR Newswire - HighBeam Research BioMarin and Alliant announce FDA approval of Orapred ODT. - Jun 1, 2006 The Orapred product line, which includes Orapred (prednisolone sodium phosphate oral solution) and Orapred ODT, is prescribed primarily for acute ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Press Release: Market Gainer begins tracking BioMarin Pharmaceutical ... - Mar 16, 2006 ...to the Orapred(R) (prednisolone sodium phosphate oral solution) product line, ... ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... Pay-Per-View - M2 Presswire - HighBeam Research Competitors by Product Report - Aug 11, 2007 K-V Pharmaceutical Company (KV/A) Products:. Ethex Prednisolone Sodium Phosphate Oral Solution/Syrup. Teva Pharmaceutical Industries Ltd (ADR) (TEVA) ... $75.00 - Revere Reports - Revere Article: Hydrotherapy excels as safe, tolerable bowel prep.(Digestive... - Dec 1, 2006 Orapred (prednisolone sodium phosphate) oral solution is approved as a treatment for children over 1 month of age with asthma and other inflammatory ... Pay-Per-View - Family Practice News - HighBeam Research WHO expert committee on specifications for pharmaceutical preparations... - Aug 1, 2005 ...prednisolone acetate 100mg 289030 9930393 prednisolone hemisuccinate 200mg 195196 9930394 prednisolone sodium phosphate 200mg 194190 9930395 prednisone ... Free with registration - Technical Report Series - AccessMyLibrary.com New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes … - Aug 16, 2005 ...per 1 mcg 5.72 J2640 Injection, prednisolone sodium phosphate, 1.20 up to 20 mg J2650 Injection, prednisolone acetate, up to 1 ml 0.78 J2670 Injection, ... Pay-Per-View - New Jersey Administrative Code - Loislaw Drug/Medical Device Report Nycomed Holding AS - Feb 23, 2008 ...(Prednisolone Sodium Phosphate Orally Disintegrating. Tablet). -. Forest Laboratories, Inc. (FRX) / Aerobid (Flunisolide) ... $70.00 - Revere Reports - Revere Florida Administrative Code - 64B13-18.002 Formulary of Topical... - Jul 5, 2005 0.6%, 1.0% (alone and in combination); (c) Prednisolone sodium phosphate — 0.125%, 0.25%, 1.0% (alone and in combination); (d) Flurometholone — 0.1%, ... Pay-Per-View - Florida Administrative Code - Loislaw Top 10 drugs prescribed by pediatricians.(VITAL SIGNS) | Article from... - Jun 1, 2008 Tamiflu (oseltamivir) 1.5% Prednisolone sodium phosphate 1.2% Note: Based on 41011234 prescriptions written from January to March 2008. ... Pay-Per-View - Pediatric News - HighBeam Research Vernal keratoconjunctivitis.(CONJUNCTIVA & SCLERA)(Disease/ … - Mar 15, 2007 ...but other steroids may be equally effective, including prednisolone acetate, prednisolone sodium phosphate, fluorometholone or rimexolone. ... Free with registration - Review of Optometry - AccessMyLibrary.com Janapanese authorities reportedly advice against Tamiflu use in … - Apr 1, 2007 ...dextroamphetamine) 1.5% Tamiflu (oseltamivir) 1.5% Prednisolone sodium phosphate 1.2% Note: Based on 41011234 prescriptions written from January ... ... Pay-Per-View - Pediatric News - HighBeam Research BioMarin's 2nd-qtr 2007 loss widens to $3.9M. - Aug 20, 2007 The firm also attrbuted its disappointing results to lower royalties from Orapred (prednisolone sodium phosphate oral solution). Income from this product ... $9.94 - Pharma Marketletter - Alacra Store Limited evidence base exists to guide management of HSV keratitis: … - Dec 15, 2006 ...also receiving topical prednisolone sodium phosphate (Inflamase, Novartis Ophthalmics) and trifluridine (Viroptic, Monarch Pharmaceuticals Inc.). ... Free with registration - Ophthalmology Times - AccessMyLibrary.com BioMarin and Serono Announce Positive Results From Phase 3 Clinical … - Mar 15, 2006 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin And Serono Form Strategic ALLIANCE for the Development and … - May 16, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma, ... Free with registration - PR Newswire - AccessMyLibrary.com Worrisome hemangiomas require intervention.(Pediatric Dermatology) - Oct 1, 2007 She uses Orapred syrup (prednisolone sodium phosphate) which comes in a concentration of 15 mg/5 mL. She usually starts with a dose of 2 mg/kg per day as ... $4.95 - Skin & Allergy News - ECNext BioMarin Receives FDA Fast Track Designation for Phenoptin for PKU. - Jan 25, 2006 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin to Present at Cowen & Co. 26th Annual Health Care Conference - Feb 27, 2006 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... RedOrbit BioMarin Appoints New Chief Financial Officer - Aug 23, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... RedOrbit BioMarin submits NDA to US FDA for ODT prednisolone.(BioMarin … - Aug 8, 2005 US Food and Drug Administration for a new formulation of the anti-inflammatory Orapred (prednisolone sodium phosphate) orally disintegrating tablets. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com BioMarin Announces US Launch of Naglazyme for MPS VI - Jun 21, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma. ... RedOrbit BioMarin to Present at the NewsMakers in the Biotech Industry … - Sep 7, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... RedOrbit BioMarin's Shares Move On Phenoptin Phase III Success - Mar 17, 2006 BioMarin to license out North American rights to the Orapred (prednisolone sodium phosphate) product line, including the already marketed oral solution, ... BioWorld Online - BioWorld Online BioMarin to Present at the BIO Investor Forum Conference - Oct 13, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... RedOrbit BioMarin Announces Positive Opinion for Naglazyme From European … - Sep 15, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... RedOrbit CIMA LABS Drug Delivery Technology Used in Orapred ODT(TM) - Jun 19, 2006 ...used by BioMarin Pharmaceutical Inc. and Alliant Pharmaceuticals, Inc. in Orapred ODT(TM) (prednisolone sodium phosphate orally disintegrating tablets). ... RedOrbit FDA accepts BioMarin's Orapred ODT filing.(Food and Drug … - Oct 24, 2005 The US Food and Drug Administration has accepted for filing BioMarin Pharmaceutical's New Drug Application for Orapred ODT (prednisolone sodium phosphate ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Agency of record.(Industry News)(marketing contracts of McIK Healthcar... - Oct 1, 2006 Inc.'s (Alpharetta, GA) Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), indicated for the treatment of asthma in children. Free with registration - Product Management Today - AccessMyLibrary.com FDA Approves Orapred ODT - Jun 5, 2006 The FDA has approved BioMarin Pharmaceutical's and Alliant Pharmaceuticals' Orapred ODT (prednisolone sodium phosphate) orally-disintegrating tablets, ... Facts and Comparisons Manufacturers add to product portfolios.(approvals for drugs) - May 2, 2005 Under the authorized generics agreement BioMarin is manufacturing a private label version of the oral solution (prednisolone sodium phosphate EQ 15-mg ... Free with registration - Chain Drug Review - AccessMyLibrary.com BioMarin and Alliant in Licensing Deal - Mar 17, 2006 Orapred is the leading brand of liquid prednisolone sodium phosphate used to treat exacerbations of asthma and other inflammatory diseases and conditions in ... RedOrbit Product news from the 06/06/06 News Brief - Jun 6, 2006 BioMarin Pharmaceutical and Alliant Pharmaceuticals said the FDA has approved marketing of Orapred ODT (prednisolone sodium phosphate orally disintegrating ... Medical Marketing & Media - Medical Marketing and Media BioMarin Announces Closing of $295 Million Concurrent Public Offerings... - Mar 30, 2006 Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... Free with registration - PR Newswire - AccessMyLibrary.com Hemangiomas of Infancy Treatment of Ulceration in the Head and Neck - May 26, 2005 Systemic corticosteroids (prednisolone sodium phosphate, 3 mg/mL) were administered along with a topical corticosteroid cream on the ulcer. ... Archives of Facial Plastic Surgery BioMarin to Present at the Leerink Swann & Company/MEDACorp … - Apr 20, 2006 Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... Free with registration - PR Newswire - AccessMyLibrary.com Product news from the 06/13/06 News Brief - Jun 13, 2006 Georgia, announced that the FDA has granted marketing approval for Orapred ODT (prednisolone sodium phosphate orally disintegrating tablets), ... Medical Marketing & Media - Medical Marketing and Media Merger and Acquisition Scenario - Jan 27, 2007 The products include Aldurazyme (laronidase), Naglazyme (galsulfase) and Orapred (prednisolone sodium phosphate oral solution). Aldurazyme is being marketed ... $250.00 - Revere Reports - Revere Aczone Gel, 5% and Adderall XR.(New & Approved) | Article from … - Sep 1, 2005 ...(methylphenidate) 1.8% Adderall XR (amphetamine/ dextroamphetamine) 1.5% Tamiflu (oseltamivir) 1.5% Prednisolone sodium phosphate 1.2% Note: Based ... ... Pay-Per-View - Pediatric News - HighBeam Research BioMarin to Present at the Rodman and Renshaw Techvest 7th Annual … - Oct 31, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... $4.95 - PR Newswire - ECNext BioMarin to Present at the Rodman and Renshaw 3rd Annual Global … - May 8, 2006 Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... $4.95 - PR Newswire - ECNext BioMarin Announces Appointment of Jean-Jacques Bienaime as Chief … - May 12, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I) and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma, ... $4.95 - PR Newswire - ECNext BioMarin and OrbiMed Settle Proxy Contest. - Jun 1, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma. ... $4.95 - PR Newswire - ECNext BioMarin Announces Public Offering of 8,500,000 Shares of Common … - Jul 14, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma. ... $4.95 - PR Newswire - ECNext BioMarin Announces First Quarter 2005 Financial Results. - May 5, 2005 Net sales of Orapred(R) (prednisolone sodium phosphate oral solution), including its branded and authorized generic products, in the first quarter of 2005 ... $4.95 - PR Newswire - ECNext BioMarin Announces Fourth Quarter and Year-End 2004 Financial … - Feb 23, 2005 ...(prednisolone sodium phosphate oral solution)-related intangible assets resulting from the introduction of a non- taste-masked generic competitor. ... $4.95 - PR Newswire - ECNext BioMarin to Present at the SG Cowen & Co. 6th Annual Global Health … - Nov 3, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... $4.95 - PR Newswire - ECNext Press Release: BioMarin Announces Appointment of Stephen Aselage as … - Jun 21, 2005 Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for severe asthma. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: BioMarin to Present at the Rodman and Renshaw … - Oct 31, 2005 ...(laronidase) for mucopolysaccharidosis I (MPS I), and Orapred(R) (prednisolone sodium phosphate oral solution) for inflammatory conditions. ... Pay-Per-View - PR Newswire - HighBeam Research Finance; Biopharmaceutical firm reports loss of $1.28 per share - Mar 28, 2005 ...(prednisolone sodium phosphate oral solution)-related intangible assets resulting from the introduction of a non- taste-masked generic competitor. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Bausch & Lomb Inc acquires a minority stake in Shandong Chia Tai... - Sep 26, 2005 Alrex also represents a branded…prednisolone sodium phosphate #% Solution Bausch & Lomb Lotemax / loteprednol etabonate #.#…BOE) Leading players such as ... Pay-Per-View - deals - Alacra Store Merger and Acquisition Scenario - Aug 26, 2006 The products include Aldurazyme (laronidase), Naglazyme (galsulfase) and Orapred (prednisolone sodium phosphate oral solution). Aldurazyme is being marketed ... $250.00 - Revere Reports - Revere Press Release: BioMarin Announces Closing of $295 Million Concurrent ... - Mar 30, 2006 Additionally, BioMarin has rights to receive payments and royalties related to Orapred(R) (prednisolone sodium phosphate oral solution). ... Pay-Per-View - PR Newswire - HighBeam Research Brand Names/Synonyms: Prednisolone sodium phosphate is also known by the following brand names and/or synonyms.Delta.-Cortef; .Delta.-Stab; A-Methapred; Ak-Pred; Ak-Tate; Alphadrol; Articulose-50; CCRIS 980; Chloroptic-P S.O.P.; Co-Hydeltra; Codelcortone; Cordrol; Cortalone; Cotogesic; Cotolone; Decaprednil; Decortin H; Delcortol; Delta F; Delta-Cortef; Delta-Stab; Deltacortenol; Deltacortril; Deltacortril Enteric; Deltahydrocortisone; Deltasolone; Deltisilone; Depo-Medrol; Derpo Pd; Dexa-Cortidelt Hostacortin H; Di-Adreson F; Dicortol; Donisolone; Dydeltrone; Eazolin D; Econopred; Econopred Plus; Erbacort; Erbasona; Estilsona; Fernisolone; Fernisolone P; Fernisolone-P; Flamasone; HSDB 3385; Hostacortin H; Hydeltra; Hydeltra-Tba; Hydeltrasol; Hydeltrone; Hydrodeltalone; Hydrodeltisone; Hydroretrocortin; Hydroretrocortine; I-Pred; Inflamase Forte; Inflamase Mild; K 1557; Key-Pred; Klismacort; Lentosone; Lite Pred; M-Predrol; Medrol; Medrol Acetate; Metacortandralone; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Sodium Succinate; Meti-Derm; Meticortelone; Meticortelone;Sterolone; Metreton; NSC 9120; NSC9900; Nisolone; Nor-Pred T.B.A.; Ocu-Pred; Ocu-Pred Forte; Ophtho-Tate; Orapred; PRDL; Panafcortelone; Paracortol; Paracotol; Pediapred; Precortalon; Precortancyl; Precortilon; Precortisyl; Pred Forte; Pred Mild; Predair; Predair A; Predair Forte; Predalone 50; Predalone T.B.A.; Predate Tba; Predate-50; Predcor-25; Predcor-50; Predcor-Tba; Predisolone Sodium Phosphate; Predne-Dome; Prednelan; Predni-Dome; Prednicen; Predniliderm; Predniretard; Prednis; Prednisolona [Inn-Spanish]; Prednisolone; Prednisolone Acetate; Prednisolone Sodium Phosphate; Prednisolone Tebutate; Prednisolone [Ban:Inn:Jan]; Prednisolonum [Inn-Latin]; Predonin; Predonine; Prelone; Prenolone; Rolisone; Scherisolon; Solone; Solu-Medrol; Steran; Sterane; Sterolone; Supercortisol; Ulacort; Ultra Pred; Ultracorten H; Ultracortene H; Ultracortene-H; Ultracortene-Hydrogen Drug Category: Prednisolone sodium phosphate is categorized under the following by the FDA: Antineoplastic Agents; Glucocorticoids; Anti-inflammatory Agents; Adrenergic Agents; ATC:A07EA01; ATC:C05AA04; ATC:D07AA01; ATC:D07AA03; ATC:D07AC14; Dosage Forms: SOLUTION Absorption: Readily absorbed by gastrointestinal tract, peak plasma concentration is reached 1-2 hours after administration Interactions: Not Available Chemical IUPAC Name: 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |